The escalating prevalence of Type-2 diabetes mellitus (T2DM) presents a formidable challenge to global healthcare systems, with its multifaceted complications imposing substantial burdens on individuals and societies alike. Among these complications, peripheral artery disease (PAD) assumes particular significance due to its propensity to precipitate severe outcomes such as diabetic foot ulcers and limb amputations. [2,10] While conventional management approaches encompass pharmacological interventions, lifestyle modifications, and surgical interventions, their efficacy may vary, necessitating exploration of alternative modalities. Buerger Allen Exercise (BAE) has emerged as a promising non-pharmacological intervention aimed at ameliorating compromised peripheral circulation in T2DM patients. Comprising a regimen of targeted physical exercises, BAE seeks to enhance blood flow to the lower extremities through mechanisms including muscle pumping and gravity modulation. Despite anecdotal evidence suggesting the efficacy of BAE, a comprehensive evaluation of its effectiveness, optimal implementation strategies, and underlying mechanisms remains elusive. To address this gap, this systematic review undertakes a meticulous synthesis of existing literature on the efficacy of BAE in improving peripheral circulation and mitigating diabetic foot complications in T2DM patients. A systematic search of electronic databases identified 20 pertinent studies published between 2015 and 2022, encompassing diverse methodological approaches such as randomized controlled trials, quasi-experimental designs, and longitudinal studies. Analysis of the compiled studies reveals consistent improvements in key indicators of peripheral circulation following BAE intervention. Notably, enhancements in the ankle-brachial index (ABI), perfusion scores, and Doppler ultrasound findings underscore BAE's potential to enhance vascular function and mitigate diabetic foot complications. Moreover, reductions in limb pain and improvements in overall quality of life further underscore the multifaceted benefits of BAE in T2DM management. However, methodological heterogeneity across studies and limited long-term data necessitate cautious interpretation of findings. Future research endeavors should focus on elucidating the mechanistic underpinnings of BAE's beneficial effects, standardizing intervention protocols, and assessing patient adherence. By addressing these knowledge gaps, healthcare providers can optimize the integration of BAE into comprehensive diabetes management strategies, thereby enhancing vascular health and patient outcomes in T2DM. Through evidence-based recommendations, this review seeks to catalyze the judicious incorporation of BAE as a valuable adjunctive therapy in the management of T2DM-related vascular complications.